Nationwide Fund Advisors’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-178,212
Closed -$2.69M 764
2017
Q3
$2.69M Buy
178,212
+9,503
+6% +$143K 0.01% 1315
2017
Q2
$1.7M Buy
168,709
+36,764
+28% +$370K 0.01% 1503
2017
Q1
$941K Buy
131,945
+13,563
+11% +$96.7K ﹤0.01% 1786
2016
Q4
$588K Sell
118,382
-2,335
-2% -$11.6K ﹤0.01% 2091
2016
Q3
$893K Buy
120,717
+8,392
+7% +$62.1K ﹤0.01% 1859
2016
Q2
$613K Buy
112,325
+8,756
+8% +$47.8K ﹤0.01% 2042
2016
Q1
$892K Sell
103,569
-2,028
-2% -$17.5K ﹤0.01% 1779
2015
Q4
$1.02M Buy
105,597
+1,754
+2% +$17K ﹤0.01% 1722
2015
Q3
$1.45M Buy
103,843
+12,253
+13% +$171K 0.01% 1538
2015
Q2
$1.3M Buy
+91,590
New +$1.3M 0.01% 1707
2014
Q2
Sell
-24,464
Closed -$51K 3339
2014
Q1
$51K Hold
24,464
﹤0.01% 2854
2013
Q4
$57K Hold
24,464
﹤0.01% 3055
2013
Q3
$57K Buy
24,464
+602
+3% +$1.4K ﹤0.01% 3036
2013
Q2
$56K Buy
+23,862
New +$56K ﹤0.01% 2936